Abdel Majid A. Adam / Journal of Molecular Structure 1030 (2012) 26–39
39
[4] Ö. Karadasß, Ö.K. Omaç, F. Tok, A. Özgül, Z. Odabasßı, J. Neurol. Sci. 316 (2012) 76.
[5] Y. Liao, J. Chou, Mater. Chem. Phys. 114 (2009) 542.
[6] T. Roy, K. Dutta, M.K. Nayek, A.K. Mukherjee, M. Banerjee, B.K. Seal, J. Chem.
Soc., Perkin Trans. 2 (1999) 531.
[7] F.P. Fla, J. Palou, R. Valero, C.D. Hall, P. Speers, J. Chem. Soc., Perkin Trans. 2
(1991) 1925.
[8] D.K. Roy, A. Saha, A.K. Mukherjee, Spectrochim. Acta A 61 (2005) 2017.
[9] A.M. Slifkin, Charge-Transfer Interaction of Biomolecules, Academic Press, New
York, 1971.
[10] A. Dozal, H. Keyzer, H.K. Kim, W.W. Wang, Int. J. Antimicrob. Agent 14 (2000)
261.
[11] A. Korolkovas, Essentials of Medical Chemistry, second ed., Wiley, New York,
1998 (Chapter 3).
[12] F.M. Abou Attia, Il Farmaco 55 (2000) 659.
[13] K. Basavaiah, Il Farmaco 59 (2004) 315–321.
[14] G.A. Saleh, H.F. Askal, M.F. Radwan, M.A. Omar, Talanta 54 (2001) 1205.
[15] H. Salem, J. Pharm. Biomed. Anal. 29 (2002) 527.
[16] M. Pandeeswaran, E.H. El-Mossalamy, K.P. Elango, Int. J. Chem. Kinet. 41
(2009) 787.
[17] M. Pandeeswaran, K.P. Elango, Spectrochim. Acta A 75 (2010) 1462.
[18] F. Yakuphanoglu, M. Arslan, Solid State Commun. 132 (2004) 229.
[19] F. Yakuphanoglu, M. Arslan, Opt. Mater. 27 (2004) 29.
[20] F. Yakuphanoglu, M. Arslan, M. Kucukislamoglu, M. Zengin, Sol. Energy 79
(2005) 96.
[21] B. Chakraborty, A.S. Mukherjee, B.K. Seal, Spectrochim. Acta A 57 (2001) 223.
[22] M. Krishnamurthy, K. Surendrababu, U. Muralikrishna, Indian J. Chem. 27A
(1988) 669.
[23] S.M. Andrade, S.M.B. Costa, R. Pansu, J. Colloid Interface Sci. 226 (2000) 260.
[24] R. Dabestani, K.J. Reszka, M.E. Sigman, J. Photochem. Photobiol., A 117 (1998)
223.
[25] R. Jakubiak, Z. Bao, L. Rothberg, Synth. Met. 114 (2000) 61.
[26] K. Takahasi, K. Horino, T. Komura, K. Murata, Bull. Chem. Soc. Jpn. 66 (1993)
733.
[27] A. Eychmuller, A.L. Rogach, Pure Appl. Chem. 72 (2000) 179.
[28] K. Brueggermann, R.S. Czernuszewicz, J.K. Kochi, J. Phys. Chem. 96 (1992)
4405.
[29] S.K. Das, G. Krishnamoorthy, S.K. Dofra, Can. J. Chem. 78 (2000) 191.
[30] G. Jones, J.A.C. Jimenez, Tetrahedron Lett. 40 (1999) 8551.
[31] G. Smith, D.E. Lynch, K.A. Byriel, C.H.L. Kennard, J. Chem. Crystallogr. 27 (1997)
307.
[32] G. Smith, D.E. Lynch, R.C. Bott, Aust. J. Chem. 51 (1998) 159.
[33] G. Smith, R.C. Bott, A.D. Rae, A.C. Willis, Aust. J. Chem. 53 (2000) 531.
[34] D.A. Skoog, Principle of Instrumental Analysis, third ed., Saunders, New York,
USA, 1985 (Chapter 7).
[35] H.A. Benesi, J.H. Hildebrand, J. Am. Chem. Soc. 71 (1949) 2703.
[36] R. Abu-Eittah, F. Al-Sugeir, Can. J. Chem. 54 (1976) 3705.
[37] A.W. Bauer, W.M. Kirby, C. Sherris, M. Turck, Am. J. Clin. Pathol. 45 (1966) 493.
[38] M.A. Pfaller, L. Burmeister, M.A. Bartlett, M.G. Rinaldi, J. Clin. Microbiol. 26
(1988) 1437.
B. subtilis
E. coli
P. aeuroginosa
S. aureus
Fig. 11. Statistical representation for antibacterial activity of PC-HCl complexes.
bacterial results, whereas Amphotericin B was used as a standard
drug for comparison of the antifungal results. The obtained screen-
ing results are listed in Table 9 and are statistically presented in
Fig. 11. The results indicated that only the [(PC-HCl)(PA)] complex
exhibits moderate antibacterial activity against the growth of the
tested bacterial strains. The [(PC-HCl)(QL)] complex exhibits a mod-
erate-to-weak antibacterial activity against all of the Gram-positive
and Gram-negative bacteria species, whereas the [(PC-HCl)(TCNQ)]
complex had no influence on the antibacterial profile of all of the
tested strains (except E. coli). The data reveal that all of the three
complexes exhibited no inhibitory activity against the fungi species.
[39] D.J. Beecher, A.C. Wong, Appl. Environ. Microbiol. 60 (1994) 1646.
[40] National Committee for Clinical Laboratory Standards, Reference Method for
Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming
Filamentous Fungi: Proposed Standard M38-A, NCCLS, Wayne, PA, USA, 2002.
[41] National Committee for Clinical Laboratory Standards, Method for Antifungal
Disk Diffusion Susceptibility Testing of Yeast: Proposed Guideline M44-P,
NCCLS, Wayne, PA, USA, 2003.
[42] National Committee for Clinical Laboratory Standards, Methods for
Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Approved
Standard M11-A3, NCCLS, Wayne, PA, USA, 1993.
[43] H. Tsubomura, R.P. Lang, J. Am. Chem. Soc. 83 (1961) 2085.
[44] R. Rathone, S.V. Lindeman, J.K. Kochi, J. Am. Chem. Soc. 119 (1997).
[45] G. Aloisi, S. Pignataro, J. Chem. Soc., Faraday Trans. 69 (1972) 534.
[46] G. Briegleb, J. Czekalla, Z. Physikchem, Frankfurt 24 (1960) 237.
[47] G. Briegleb, Z. Angew. Chem. 72 (1960) 401;
G. Briegleb, Z. Angew. Chem. 76 (1964) 326.
[48] A.N. Martin, J. Swarbrick, A. Cammarata, Physical Pharmacy, third ed., Lee and
Febiger, Philadelphia, PA, 1969. p. 344.
[49] M.S. Refat, A. Elfalaky, E. Elesh, J. Mol. Struct. 990 (2011) 217.
[50] M. Pandeeswaran, K.P. Elango, Spectrochim. Acta A 65 (2006) 1148.
[51] M.S. Refat, L.A. El-Zayat, O.Z. Yesßilel, Spectrochim. Acta A 75 (2010) 745.
[52] M.S. Refat, H.A. Saad, A.A. Adam, J. Mol. Struct. 995 (2011) 116.
[53] L.J. Bellamy, The Infrared Spectra of Complex Molecules, Chapman & Hall,
London, 1975.
4. Conclusions
Charge-transfer interactions between the drug procaine hydro-
chloride (PC-HCl) as a donor and quinol (QL), picric acid (PA) or
7,70,8,80-tetracyanoquinodimethane (TCNQ) as a
p-acceptor were
extensively studied in both solid and liquid phase at room temper-
ature. It is observed that the reaction stoichiometry is 1:1, and the
resulting CT complexes were shown to have the general formula:
[(PC-HCl)(acceptor)]. The interaction between the donor and QL
and PA acceptors was due to transfer of proton from acceptor to
nitrogen atom of donor to make hydrogen bonding, where the inter-
action mode between PC-HCl and the TCNQ acceptor occurs through
the migration of the H+ ion from the NH2 in the donor to one of the
four cyano groups in the TCNQ acceptor to form a positive ion
(AC„N+H) that associates with the anion to form ion pairs. The ob-
tained complexes are semi-crystalline material and thermally sta-
ble. Physical parameters such as formation constant (KCT), molar
extinction coefficient (
e
CT) and other spectroscopic data and as well
[54] R. Bharathikannan, A. Chandramohan, M.A. Kandhaswamy, J. Chandrasekaran,
R. Renganathan, V. Kandavelu, Cryst. Res. Technol. 43 (6) (2008) 683.
[55] R.D. Kross, V.A. Fassel, J. Am. Chem. Soc. 79 (1957) 38.
[56] M.S. Refat, J. Mol. Struct. 985 (2011) 380.
[57] G.G. Mohamed, Shaban M. Khalil, M.A. Zayed, M. Abd El-Hamid El-Shall, J.
Pharm. Biomed. Anal. 28 (2002) 1127.
as the kinetic parameters (Eꢀ, A,
D
Sꢀ, Hꢀ and Gꢀ) have been esti-
D
D
mated. Only the complex obtained using PA acceptor shows moder-
ate antibacterial activity against various strains.
[58] A.S. Amine, M.E. Moustafa, Y.M. Issa, Microchem. J. 50 (1994) 6.
[59] M.S. Refat, H.A. Saad, A.A. Adam, Spectrochim. Acta A 79 (2011) 672.
[60] A.W. Coats, J.P. Redfern, Nature (London) 201 (1964) 68.
[61] H.H. Horowitz, G. Metzger, Anal. Chem. 35 (1963) 1464.
[62] S.J.S. Qazi, A.R. Rennie, J.K. Cockcroft, M. Vickers, J. Colloid Interface Sci. 338
(2009) 105.
References
[1] J. Yuan, J. Yin, E. Wang, J. Chromatogr., A 1154 (2007) 368.
[2] N. Li, Y. Chi, J. Wang, J. Duan, G. Chen, Luminescence 18 (2003) 125.
[3] Y. Chen, K. Lu, R. Hsiao, Y. Lee, H. Tsai, C.H. Lin, M. Tsai, J. Comp. Biochem.
Physiol., C 148 (2008) 128.